 Colin Shearn
Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Carbonylation | 12 | 2025 | 57 | 3.590 |
Why?
| | Cholestasis | 10 | 2023 | 213 | 3.530 |
Why?
| | Aldehydes | 16 | 2025 | 141 | 3.400 |
Why?
| | Liver | 22 | 2025 | 1895 | 2.770 |
Why?
| | PTEN Phosphohydrolase | 7 | 2018 | 164 | 2.450 |
Why?
| | Liver Diseases, Alcoholic | 12 | 2019 | 98 | 2.380 |
Why?
| | Bile Acids and Salts | 7 | 2024 | 163 | 2.130 |
Why?
| | Oxidative Stress | 16 | 2025 | 1350 | 1.870 |
Why?
| | Ethanol | 12 | 2019 | 632 | 1.750 |
Why?
| | Antioxidants | 7 | 2023 | 549 | 1.620 |
Why?
| | Glutathione Transferase | 8 | 2019 | 96 | 1.620 |
Why?
| | Cholangitis, Sclerosing | 4 | 2024 | 61 | 1.580 |
Why?
| | Parenteral Nutrition | 5 | 2024 | 102 | 1.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2016 | 436 | 1.320 |
Why?
| | Ileum | 2 | 2024 | 112 | 1.000 |
Why?
| | Fatty Liver | 3 | 2014 | 254 | 0.990 |
Why?
| | Mice | 38 | 2025 | 18338 | 0.920 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2024 | 1212 | 0.920 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5989 | 0.910 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 366 | 0.890 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 14 | 0.880 |
Why?
| | Insulin-Secreting Cells | 3 | 2025 | 392 | 0.860 |
Why?
| | Signal Transduction | 11 | 2024 | 5202 | 0.840 |
Why?
| | Thioredoxins | 3 | 2018 | 31 | 0.810 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2019 | 372 | 0.720 |
Why?
| | Abdominal Injuries | 1 | 2023 | 130 | 0.710 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 191 | 0.710 |
Why?
| | Animals | 41 | 2025 | 38141 | 0.700 |
Why?
| | Protein Processing, Post-Translational | 4 | 2016 | 468 | 0.660 |
Why?
| | Circadian Rhythm | 1 | 2024 | 512 | 0.610 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 37 | 0.610 |
Why?
| | Hepatocytes | 5 | 2021 | 224 | 0.590 |
Why?
| | Peroxiredoxins | 2 | 2018 | 26 | 0.580 |
Why?
| | Disease Models, Animal | 13 | 2025 | 4559 | 0.580 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.560 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 100 | 0.550 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2017 | 265 | 0.540 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 117 | 0.530 |
Why?
| | Hepatitis | 1 | 2017 | 43 | 0.520 |
Why?
| | Liver Diseases | 2 | 2021 | 304 | 0.510 |
Why?
| | Liver Cirrhosis | 3 | 2024 | 287 | 0.500 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 207 | 0.500 |
Why?
| | Superoxide Dismutase | 5 | 2019 | 303 | 0.500 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 262 | 0.490 |
Why?
| | Liver Neoplasms | 4 | 2019 | 779 | 0.480 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.480 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 95 | 0.470 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.470 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.460 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 566 | 0.440 |
Why?
| | Insulin | 1 | 2025 | 2506 | 0.420 |
Why?
| | Alcoholism | 3 | 2018 | 821 | 0.420 |
Why?
| | Oxidants | 2 | 2012 | 103 | 0.410 |
Why?
| | ARNTL Transcription Factors | 2 | 2024 | 17 | 0.410 |
Why?
| | Diet, High-Fat | 2 | 2016 | 264 | 0.400 |
Why?
| | Mice, Knockout | 8 | 2020 | 3125 | 0.380 |
Why?
| | Inflammation | 6 | 2025 | 2883 | 0.380 |
Why?
| | Male | 30 | 2025 | 72817 | 0.370 |
Why?
| | Dietary Fats | 2 | 2018 | 308 | 0.360 |
Why?
| | Lipid Peroxidation | 4 | 2016 | 163 | 0.350 |
Why?
| | Proteomics | 5 | 2025 | 1191 | 0.340 |
Why?
| | RNA, Messenger | 6 | 2023 | 2820 | 0.340 |
Why?
| | Xenobiotics | 1 | 2011 | 31 | 0.330 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 338 | 0.320 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 445 | 0.320 |
Why?
| | Reactive Oxygen Species | 3 | 2025 | 602 | 0.320 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 27 | 0.310 |
Why?
| | Cell Proliferation | 3 | 2018 | 2499 | 0.310 |
Why?
| | Glutathione Reductase | 3 | 2019 | 24 | 0.310 |
Why?
| | Alcohol Drinking | 1 | 2016 | 837 | 0.290 |
Why?
| | Down-Regulation | 1 | 2011 | 616 | 0.280 |
Why?
| | Mitochondria | 4 | 2019 | 990 | 0.280 |
Why?
| | Blotting, Western | 4 | 2016 | 1162 | 0.280 |
Why?
| | Carcinoma | 1 | 2010 | 224 | 0.270 |
Why?
| | Autophagy | 2 | 2022 | 288 | 0.270 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 62 | 0.270 |
Why?
| | Colonic Neoplasms | 1 | 2010 | 257 | 0.260 |
Why?
| | Carcinogens | 1 | 2008 | 123 | 0.260 |
Why?
| | Catalase | 2 | 2017 | 133 | 0.260 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 56 | 0.250 |
Why?
| | NF-kappa B | 2 | 2021 | 660 | 0.250 |
Why?
| | Glutathione | 4 | 2019 | 366 | 0.230 |
Why?
| | Alanine Transaminase | 3 | 2016 | 151 | 0.230 |
Why?
| | Hep G2 Cells | 3 | 2021 | 75 | 0.230 |
Why?
| | Up-Regulation | 2 | 2019 | 848 | 0.230 |
Why?
| | Case-Control Studies | 3 | 2018 | 3619 | 0.220 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2594 | 0.220 |
Why?
| | Recombinant Proteins | 4 | 2020 | 1367 | 0.220 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 821 | 0.210 |
Why?
| | Macrophage Activation | 2 | 2023 | 186 | 0.210 |
Why?
| | Humans | 28 | 2025 | 145491 | 0.210 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 980 | 0.210 |
Why?
| | Ileitis | 1 | 2024 | 33 | 0.210 |
Why?
| | Biomarkers | 1 | 2015 | 4283 | 0.210 |
Why?
| | Phosphorylation | 3 | 2014 | 1707 | 0.200 |
Why?
| | Epithelial Cells | 1 | 2010 | 1112 | 0.200 |
Why?
| | Mice, Inbred NOD | 1 | 2025 | 613 | 0.200 |
Why?
| | Genes, Regulator | 1 | 2023 | 35 | 0.200 |
Why?
| | Lipoproteins | 2 | 2021 | 166 | 0.200 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 49 | 0.190 |
Why?
| | Fibroblast Growth Factors | 1 | 2024 | 188 | 0.190 |
Why?
| | Biliary Atresia | 1 | 2025 | 158 | 0.190 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 188 | 0.190 |
Why?
| | Prostatic Neoplasms | 1 | 2010 | 978 | 0.190 |
Why?
| | Insulin Resistance | 1 | 2011 | 1244 | 0.180 |
Why?
| | Enzyme Activation | 3 | 2013 | 762 | 0.180 |
Why?
| | Triglycerides | 2 | 2016 | 518 | 0.180 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2013 | 79 | 0.180 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 70 | 0.180 |
Why?
| | Dioxanes | 1 | 2021 | 11 | 0.170 |
Why?
| | Phytosterols | 1 | 2021 | 10 | 0.170 |
Why?
| | Isoxazoles | 1 | 2021 | 55 | 0.170 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 168 | 0.170 |
Why?
| | Oxidation-Reduction | 3 | 2019 | 1080 | 0.170 |
Why?
| | Mucoproteins | 1 | 2020 | 8 | 0.160 |
Why?
| | Female | 11 | 2025 | 78763 | 0.160 |
Why?
| | Models, Molecular | 4 | 2014 | 1614 | 0.160 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 33 | 0.160 |
Why?
| | Cholesterol | 2 | 2020 | 405 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 85 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 130 | 0.150 |
Why?
| | Gene Expression | 2 | 2021 | 1478 | 0.150 |
Why?
| | Macrophages | 2 | 2025 | 1509 | 0.150 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 181 | 0.150 |
Why?
| | Cytokines | 2 | 2025 | 2054 | 0.150 |
Why?
| | Acylation | 1 | 2019 | 30 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 581 | 0.140 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.140 |
Why?
| | Liposomes | 1 | 2020 | 259 | 0.140 |
Why?
| | PPAR alpha | 2 | 2016 | 54 | 0.140 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 84 | 0.140 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.140 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 74 | 0.130 |
Why?
| | Colon | 1 | 2020 | 308 | 0.130 |
Why?
| | Ribosomes | 1 | 2019 | 196 | 0.130 |
Why?
| | Aminobutyrates | 1 | 2018 | 31 | 0.130 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 20 | 0.130 |
Why?
| | Lung | 1 | 2011 | 4103 | 0.130 |
Why?
| | Azo Compounds | 1 | 2017 | 30 | 0.130 |
Why?
| | Taurine | 1 | 2018 | 41 | 0.130 |
Why?
| | Organ Specificity | 1 | 2018 | 312 | 0.130 |
Why?
| | Colitis | 1 | 2020 | 280 | 0.130 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 76 | 0.130 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 366 | 0.130 |
Why?
| | Gene Deletion | 2 | 2015 | 392 | 0.130 |
Why?
| | Homocystinuria | 1 | 2018 | 62 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2025 | 1076 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1261 | 0.120 |
Why?
| | Malnutrition | 1 | 2018 | 86 | 0.120 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2137 | 0.120 |
Why?
| | Lipogenesis | 1 | 2016 | 62 | 0.120 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 3537 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 96 | 0.110 |
Why?
| | Sirtuin 3 | 2 | 2019 | 58 | 0.110 |
Why?
| | Lysine | 1 | 2017 | 272 | 0.110 |
Why?
| | Middle Aged | 4 | 2019 | 36176 | 0.110 |
Why?
| | Acetylation | 4 | 2017 | 250 | 0.110 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.110 |
Why?
| | CD36 Antigens | 1 | 2014 | 32 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2015 | 396 | 0.100 |
Why?
| | Adult | 4 | 2019 | 40707 | 0.100 |
Why?
| | Proteome | 1 | 2019 | 517 | 0.100 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 84 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 134 | 0.100 |
Why?
| | DNA Primers | 2 | 2012 | 507 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2013 | 380 | 0.100 |
Why?
| | Protein Binding | 4 | 2020 | 2250 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 118 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 161 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 733 | 0.100 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 32 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 26 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2910 | 0.100 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 56 | 0.100 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 264 | 0.090 |
Why?
| | Models, Chemical | 1 | 2014 | 264 | 0.090 |
Why?
| | Computational Biology | 1 | 2017 | 687 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 1049 | 0.090 |
Why?
| | Organ Size | 1 | 2013 | 461 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 16 | 0.080 |
Why?
| | Peptide Mapping | 1 | 2011 | 62 | 0.080 |
Why?
| | Adiponectin | 1 | 2013 | 240 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2582 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 73 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 82 | 0.080 |
Why?
| | Binding Sites | 2 | 2020 | 1313 | 0.080 |
Why?
| | Fenretinide | 1 | 2010 | 3 | 0.080 |
Why?
| | Crotonates | 1 | 2010 | 7 | 0.080 |
Why?
| | Receptors, Estrogen | 1 | 2013 | 400 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 883 | 0.080 |
Why?
| | Toluidines | 1 | 2010 | 10 | 0.080 |
Why?
| | Hydroxybutyrates | 1 | 2010 | 15 | 0.080 |
Why?
| | Oxygen Consumption | 1 | 2013 | 718 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2010 | 138 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 318 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 935 | 0.070 |
Why?
| | Glycoproteins | 1 | 2011 | 353 | 0.070 |
Why?
| | Nitriles | 1 | 2010 | 205 | 0.070 |
Why?
| | Cell Survival | 1 | 2012 | 1094 | 0.070 |
Why?
| | Alkylation | 1 | 2008 | 26 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2025 | 3917 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 2013 | 743 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 632 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 179 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 214 | 0.070 |
Why?
| | DNA Damage | 2 | 2021 | 434 | 0.060 |
Why?
| | Base Sequence | 1 | 2011 | 2180 | 0.060 |
Why?
| | Kidney | 1 | 2015 | 1498 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2013 | 4127 | 0.060 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2007 | 41 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1710 | 0.060 |
Why?
| | Static Electricity | 1 | 2007 | 114 | 0.060 |
Why?
| | Hydrolysis | 1 | 2007 | 199 | 0.060 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2664 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 2020 | 535 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 303 | 0.060 |
Why?
| | Phospholipids | 1 | 2007 | 216 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2526 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 993 | 0.060 |
Why?
| | Skin | 1 | 2010 | 766 | 0.050 |
Why?
| | Metabolome | 2 | 2019 | 387 | 0.050 |
Why?
| | Kupffer Cells | 1 | 2025 | 52 | 0.050 |
Why?
| | Transcription Factors | 1 | 2013 | 1733 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1321 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 161 | 0.050 |
Why?
| | Amino Acids | 2 | 2018 | 521 | 0.050 |
Why?
| | Rats | 1 | 2011 | 5581 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 20 | 0.040 |
Why?
| | Systems Analysis | 1 | 2021 | 22 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 80 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 110 | 0.040 |
Why?
| | Intestinal Diseases | 1 | 2021 | 43 | 0.040 |
Why?
| | Apoptosis | 1 | 2010 | 2411 | 0.040 |
Why?
| | Bilirubin | 1 | 2021 | 99 | 0.040 |
Why?
| | Fatty Acids | 2 | 2016 | 459 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 127 | 0.040 |
Why?
| | Infliximab | 1 | 2021 | 111 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 139 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 19 | 0.040 |
Why?
| | Sphingomyelins | 1 | 2020 | 22 | 0.040 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 17 | 0.040 |
Why?
| | Calcium | 1 | 2007 | 1190 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 61 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 335 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 93 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 123 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 146 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 101 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 390 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 335 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 491 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 343 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 48 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 266 | 0.030 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1769 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.030 |
Why?
| | Cystathionine beta-Synthase | 1 | 2018 | 65 | 0.030 |
Why?
| | Aged | 1 | 2017 | 26125 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2016 | 20 | 0.030 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2016 | 5 | 0.030 |
Why?
| | Sumoylation | 1 | 2016 | 16 | 0.030 |
Why?
| | Oxides | 1 | 2016 | 49 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 857 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 242 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 4093 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 41 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 31 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 87 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 95 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 209 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 58 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 279 | 0.020 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 145 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 9 | 0.020 |
Why?
| | Antibodies | 1 | 2014 | 398 | 0.020 |
Why?
| | Actins | 1 | 2014 | 421 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 268 | 0.020 |
Why?
| | Fibrosis | 1 | 2014 | 551 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2012 | 147 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 475 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 850 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 118 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 529 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2862 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 85 | 0.020 |
Why?
| | NAD | 1 | 2011 | 82 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 371 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 975 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1038 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 1026 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 744 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1199 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 709 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2189 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1439 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2355 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22485 | 0.010 |
Why?
| | Child | 1 | 2016 | 22680 | 0.010 |
Why?
|
|
Shearn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|